Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

• NAICS93.855

• RFA-AI-27-004-Full-Announcement.html

  text/html;charset=UTF-8194 KBNot yet available

• National Institutes of Health
  minnicozzim@niaid.nih.gov301-402-2541